Featured
Health Topics
- Analytical, Diagnostic and Therapeutic Techniques and Equipment1 See more
-
Chemicals and Drugs14
See more
-
Diseases32
See more
- Animal Diseases 1
- Bacterial Infections and Mycoses 3
- Cardiovascular Diseases 2
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 6
- Digestive System Diseases 7
- Endocrine System Diseases 2
- Female Urogenital Diseases and Pregnancy Complications 5
- Hemic and Lymphatic Diseases 4
- Immune System Diseases 6
- Male Urogenital Diseases 3
- Musculoskeletal Diseases 2
- Neoplasms 11
- Nervous System Diseases 1
- Nutritional and Metabolic Diseases 1
- Occupational Diseases 1
- Pathological Conditions, Signs and Symptoms 9
- Respiratory Tract Diseases 3
- Skin and Connective Tissue Diseases 3
- Stomatognathic Diseases 2
- Virus Diseases 5
- Phenomena and Processes1 See more
- Psychiatry and Psychology2 See more
Search Clinical Trials
Not Yet Recruiting
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells (External Link)
The study team will collect up to 18 teaspoons of patients' blood. This will be used this blood to grow T cells. The study team then grows the T cells …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
Toddler Biomarker of Nutrition Study (External Link)
Young children rely on their foods and drinks for the nutrients they need to grow, like energy, protein, vitamins, and minerals. However, it is challenging for researchers to study children's …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
Zinc Supplementation in Sickle Cell Disease (External Link)
The investigators propose a two-arm, double-blinded, Phase II study comparing the effects of two different daily doses of zinc (25 and 40 mg/day) in 34 patients with SCD-SS aged 15-35 …
Baylor Role:
Collaborator
Not Yet Recruiting
Locating Biomarkers in OCD Through Behavioral Tasks (External Link)
This is a research study in which BCM is collaborating with Brown University/Butler Hospital and University of Pittsburgh. BCM and Butler Hospital will be enrolling sites. Brown University and University …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
OCD Biomarker Survey Employing sEEG and Stimulation: The OBSESS Trial (External Link)
Obsessive-compulsive disorder (OCD) has a lifetime prevalence of 2-3% and is a major cause of global disability. Deep brain stimulation (DBS) is an effective treatment for patients with severe, treatment-resistant …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer (External Link)
To make the T cells, the investigators will take the patient's blood and stimulate it with growth factors to make T cells grow. Investigators use a retrovirus to insert HER …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management (External Link)
The management of pelvic floor overactivity (PFOA) using focal BoNT injection has been gaining clinical interest. Evidence has shown that BoNT injections to the levator ani in patients with CPP …
Baylor Role:
Collaborator
Not Yet Recruiting
Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy (External Link)
This is an interventional single arm study. The aim is to see if sentinel lymph nodes marked with a magnetic tracer injected before preoperative chemotherapy can be detected at surgery …
Baylor Role:
Collaborator
Not Yet Recruiting
VIRTUALLY SUPERVISED TELE-EXERCISE PLATFORM FOR ACCELERATING PLANTAR WOUND HEALING (External Link)
Foot ulceration is the most common and costly late complication of diabetes, with morbidity and mortality being worse than many cancers. It is estimated that up to one-third of people …
Baylor Role:
Lead Sponsor
Not Yet Recruiting
Neoadjuvant Chemoimmunotherapy for Resectable Non-Metastatic Proficient Mismatch Repair (PMMR) Colon Cancer (External Link)
Once participants' eligibility has been confirmed, and participants have been registered in the study, the participants will receive immunotherapy treatment with Atezolizumab, followed by administration of CAPEOX chemotherapy for a …
Baylor Role:
Lead Sponsor